Distinguished in Glomerulonephritis

Christophe Mariat

Saint-etienne-de-valoux, FR 
Distinguished in Glomerulonephritis
Saint-etienne-de-valoux, FR 
OverviewLocationsClinical Research

Overview

Christophe Mariat practices in Saint-etienne-de-valoux, France. Mr. Mariat is rated as a Distinguished expert by MediFind in the treatment of Glomerulonephritis. His top areas of expertise are IgA Nephropathy, Glomerulonephritis, Chronic Kidney Disease, Kidney Transplant, and Nephrectomy.

His clinical research consists of co-authoring 187 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 26 articles in the study of Glomerulonephritis.

Gender
Male

Locations

Saint-etienne-de-valoux, France
Other Locations
Saint Étienne, France
Lyon, France
Saint-priest-la-vetre, France
Clermont-ferrand, France
Saint-jean-saint-germain, 42055, France
Nantes, 44093, France
University of St Etienne
Saint-etienne, France
Strasbourg, France
CHU Besançon
Besancon, France
Boulogne-billancourt, France
Reims, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury: a Multicentre, Randomized, 2-parallel Group, Superiority Trial
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury: a Multicentre, Randomized, 2-parallel Group, Superiority Trial
Enrollment Status: Terminated
Publish Date: August 26, 2025
Intervention Type: Drug
Study Drug: L-Carnitine
Study Phase: Phase 3
Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient.
Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient.
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Other
Study Phase: Not Applicable
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers on the Occurrence of S. Aureus Infections in Hemodialysis Patients
Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers on the Occurrence of S. Aureus Infections in Hemodialysis Patients
Enrollment Status: Terminated
Publish Date: December 18, 2024
Intervention Type: Other, Drug
Study Phase: Phase 4
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Phase: Phase 3
Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients
Enrollment Status: Completed
Publish Date: February 06, 2024
Intervention Type: Other
Study Phase: Not Applicable
Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months.
Double-blind Placebo-Controlled Randomized Clinical Trial of Mineralocorticoid Receptor Blockade With Eplerenone After Renal Transplantation : Effect on Graft Function at 3 Months.
Enrollment Status: Active_not_recruiting
Publish Date: June 18, 2023
Intervention Type: Drug
Study Drug: Eplerenone
Study Phase: Phase 3
Interest of Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure
Interest of Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure
Enrollment Status: Completed
Publish Date: November 21, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
Ex Vivo Evaluation of Immunity Activation Face to Staphylococcus Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients
Ex Vivo Evaluation of Immunity Activation Face to Staphylococcus Aureus Antigens and Adjuvants of a Vaccine Candidate in Cells From Haemodialysis Patients
Enrollment Status: Completed
Publish Date: December 17, 2020
Intervention Type: Biological
Study Phase: Not Applicable
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis : a Predictive Factor of Clinical Outcome? (MONITUX)
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis : a Predictive Factor of Clinical Outcome? (MONITUX)
Enrollment Status: Terminated
Publish Date: November 16, 2020
Intervention Type: Other
Platelet-associated Inflammation in Severe Sepsis
Platelet-associated Inflammation in Severe Sepsis
Enrollment Status: Completed
Publish Date: July 10, 2020
Intervention Type: Other
Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients
Evaluation of the Pharmacokinetics of Caspofungin in ICU Patients
Enrollment Status: Completed
Publish Date: June 14, 2019
Intervention Type: Drug
Study Phase: Not Applicable
Assessment of Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique: NECPAR Study
Assessment of Nephrotoxicity Associated to Parenchymal Clamping During Partial Nephrectomy Using a Microdialysis Technique: NECPAR Study
Enrollment Status: Terminated
Publish Date: May 08, 2018
Intervention Type: Procedure
Study Phase: Not Applicable
Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation - A Monocentric Study
Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation - A Monocentric Study
Enrollment Status: Completed
Publish Date: May 31, 2017
Intervention Type: Device
View 12 Less Clinical Trials

187 Total Publications

Where is the eye of the storm of eGFR formulas?
Where is the eye of the storm of eGFR formulas?
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mariat's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile